A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor.
about
Novel pharmacological approaches for the treatment of acne vulgarisAcne and smoking.Zileuton, a new efficient and safe systemic anti-acne drugThe relationship of diet and acne: A reviewAbuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.Effects of fish oil supplementation on inflammatory acne.Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.Lipid mediators in acneTreating acne with antibiotic-resistant bacterial colonization.Pathophysiology of acne.Acne vulgaris, mental health and omega-3 fatty acids: a report of cases.Pharmacotherapy of acne.New and emerging treatments in dermatology: acne.Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.Management of severe acne.Beyond acne: Current aspects of sebaceous gland biology and function.Anti-acne drugs in phase 1 and 2 clinical trials.Sebaceous gland lipids.Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit.Regulation of stearoyl-coenzyme A desaturase and fatty acid delta-6 desaturase-2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis.Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production.Modulation of sebum oxidation and interleukin-1α levels associates with clinical improvement of mild comedonal acne.‘Smoker’s acne’: a new clinical entity?
P2860
Q28241186-CEE8432D-D5E9-4BA7-BF59-5D17ADD7CE81Q33716976-16AB56E0-9E10-42C9-ADD9-3FE2BC96ACCAQ33716998-077A2C02-4FDA-4F31-BEA7-8B9B89CFBD41Q33718918-1C631958-0016-41DA-80D5-EDB13CA05F42Q34002248-D194DAFE-8ADE-4CA1-BB65-10C1CC8B6A9DQ34034611-7C8A58E7-9B76-45D8-A069-6BF5EF3F5011Q34117612-7DE5815E-5DD8-4A20-9570-6459FA1AF05EQ34143816-6C8D34EE-C19A-415D-8D0D-5B697FA07A01Q34167188-1CC63B0E-9621-45AE-9811-736DA4D29239Q36765845-13874A01-3288-4DE6-BBEC-CEF1C58663FBQ36960559-CE789868-C305-4023-9F06-4A0A24AD9CF1Q37123406-69166A3D-1EF4-47ED-B22E-A90EACE434CFQ37131011-3903A313-288C-4EF0-93EF-B93AC4EA4F5DQ37959975-14263322-BE86-4BA6-B8FC-7FD0F56AF276Q38322352-BA20EEB6-657E-45B7-8FF7-4EBBFCD3C63AQ38977482-76D3ECE4-3FD7-4D41-AD6D-DC8E795ED075Q39382177-7FEF7D0D-1C15-4265-A415-77931B5FAB1BQ39533668-F0B7D347-A80F-401E-A370-7F74F6EC396CQ40082702-0B665EA8-A38A-4F04-92CA-C9BA8FEC89A7Q42744285-832C236C-55FD-487B-9343-2884389CB119Q45190459-1D5C434C-00BA-4B32-AB42-7D91ED630B35Q46042128-14BA150A-E363-4543-945C-7ACFCA600171Q57819225-51D5B618-9834-4B54-8AB1-D5D3D71AF2E6
P2860
A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@en
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@nl
type
label
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@en
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@nl
prefLabel
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@en
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@nl
P2093
P50
P1433
P1476
A new concept for acne therapy ...... oral 5-lipoxygenase inhibitor.
@en
P2093
Christos C Zouboulis
Constantin E Orfanos
Stefan Nestoris
William J Cunliffe
Yael D Adler
P304
P356
10.1001/ARCHDERM.139.5.668
P577
2003-05-01T00:00:00Z